Last reviewed · How we verify
NCT06033391
Mobile App for Obsessive-compulsive Disorder in Adolescents
NA trial testing GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) in Obsessive-Compulsive Disorder in Adolescence in 94 participants. Completed in 24 May 2024.
24 May 2024
Quick facts
| Lead sponsor | University of Valencia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 94 |
| Start date | 9 April 2024 |
| Primary completion | 24 May 2024 |
| Estimated completion | 24 May 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents)
- GGN-AD (GG Neutral - Adolescents)
Conditions studied
- Obsessive-Compulsive Disorder in Adolescence — all drugs for Obsessive-Compulsive Disorder in Adolescence →
Sponsor
University of Valencia
Who can join
Adults 15 to 17, any sex, with Obsessive-Compulsive Disorder in Adolescence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study is to assess the efficacy of the module GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) in reducing obsessive-compulsive disorder (OCD) related maladaptive beliefs and OCD symptoms in adolescents from 15 to 18 years old. Specifically, a randomized controlled trial with two conditions (experimental and control) will be carried out in a non-clinical adolescent population to assess pre-post-intervention changes. After 14 days of using GGOC-AD, it is expected, primarily, to find a decrease in OCD-related maladaptive beliefs and OCD symptoms. As secondary results, we do not expect changes in emotional symptomatology, but we do expect an increase in self-esteem. Additionally, these changes are expected to be found in a one-month follow-up.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A mobile app to challenge obsessional beliefs in adolescents: a protocol of a two-armed, parallel randomized controlled trial.
Saman Y, Pascual-Vera B, Corberán M, Arnáez S, et al · · 2024 · cited 1× · PMID 38594680 · DOI 10.1186/s12888-024-05735-x -
A mobile app to challenge obsessional beliefs in adolescents: A protocol of a two-armed, parallel randomized controlled trial
Saman Y, Pascual-Vera B, Corberán M, Arnáez S, et al · · 2024 · DOI 10.21203/rs.3.rs-4175049/v1
Verify or expand the search:
- PubMed search for NCT06033391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obsessive-Compulsive Disorder in Adolescence
Currently open trials in the same condition.
- NCT06356090 — SPACE: a Parent-based Treatment for Pediatric OCD · NA · recruiting
- NCT05967468 — Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder · NA · active not recruiting
- NCT05609916 — CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD · NA · recruiting
- NCT03595098 — Treatment Effects of Family Based Cognitive Therapy in Children and Adolescents With Obsessive Compulsive Disorder · NA · active not recruiting
Other University of Valencia trials
Trials by the same sponsor.
- NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
- NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
- NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
- NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
- NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06033391 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Valencia
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06033391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing